Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Joseph

Showing results (1041-1050 of 1,154) with videos related to

Pageof 116
Sort By:
Science Translational Medicine|October 12, 2012
Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responsesMark L Bagarazzi, Jian Yan, Matthew P Morrow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2015
AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell CarcinomaFernando Doñate, Arthur Raitano, Kendall Morrison, et al.
Neuron|March 16, 2022
Loss of mouse Stmn2 function causes motor neuropathyIrune Guerra San Juan, Leslie A Nash, Kevin S Smith, et al.
Blood|May 12, 2019
Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8<sup>+</sup> T cells and impede CAR T-cell efficacyJaco A C van Bruggen, Anne W J Martens, Joseph A Fraietta, et al.
BJU International|June 5, 2014
A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trialMaria Pearse, Carol Fraser-Browne, Ian D Davis, et al.
Nature Communications|September 24, 2022
Interferon gamma mediates the reduction of adipose tissue regulatory T cells in human obesityDavid Bradley, Alan J Smith, Alecia Blaszczak, et al.
Diabetes Care|January 9, 2021
Insulinemic and Inflammatory Dietary Patterns Show Enhanced Predictive Potential for Type 2 Diabetes Risk in Postmenopausal WomenQi Jin, Ni Shi, Desmond Aroke, et al.
Global Health, Science and Practice|October 30, 2023
How Real-Time Case-Based Malaria Surveillance Helps Zanzibar Get a Step Closer to Malaria Elimination: Description of Operational Platform and ResourcesHumphrey R Mkali, Shabbir M Lalji, Abdul-Wahid Al-Mafazy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 18, 2019
Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid CancersAndrew R Haas, Janos L Tanyi, Mark H O'Hara, et al.
Molecular Cancer Therapeutics|August 24, 2016
The Discovery and Preclinical Development of ASG-5ME, an Antibody-Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate CancerMichael Mattie, Arthur Raitano, Kendall Morrison, et al.
Pageof 116

Showing results (1041-1050 of 1,154) with videos related to

Sort By:
Pageof 116
Science Translational Medicine|October 12, 2012
Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responsesMark L Bagarazzi, Jian Yan, Matthew P Morrow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2015
AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell CarcinomaFernando Doñate, Arthur Raitano, Kendall Morrison, et al.
Neuron|March 16, 2022
Loss of mouse Stmn2 function causes motor neuropathyIrune Guerra San Juan, Leslie A Nash, Kevin S Smith, et al.
Blood|May 12, 2019
Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8<sup>+</sup> T cells and impede CAR T-cell efficacyJaco A C van Bruggen, Anne W J Martens, Joseph A Fraietta, et al.
BJU International|June 5, 2014
A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trialMaria Pearse, Carol Fraser-Browne, Ian D Davis, et al.
Nature Communications|September 24, 2022
Interferon gamma mediates the reduction of adipose tissue regulatory T cells in human obesityDavid Bradley, Alan J Smith, Alecia Blaszczak, et al.
Diabetes Care|January 9, 2021
Insulinemic and Inflammatory Dietary Patterns Show Enhanced Predictive Potential for Type 2 Diabetes Risk in Postmenopausal WomenQi Jin, Ni Shi, Desmond Aroke, et al.
Global Health, Science and Practice|October 30, 2023
How Real-Time Case-Based Malaria Surveillance Helps Zanzibar Get a Step Closer to Malaria Elimination: Description of Operational Platform and ResourcesHumphrey R Mkali, Shabbir M Lalji, Abdul-Wahid Al-Mafazy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 18, 2019
Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid CancersAndrew R Haas, Janos L Tanyi, Mark H O'Hara, et al.
Molecular Cancer Therapeutics|August 24, 2016
The Discovery and Preclinical Development of ASG-5ME, an Antibody-Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate CancerMichael Mattie, Arthur Raitano, Kendall Morrison, et al.
Pageof 116